The US Food & Drug Administration has approved a generic version of lenacapavir (Yeztugo), the world’s only twice-a-year shot to prevent HIV – a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries, reports MedPage Today. The drug is expected to cost $40 a year per person in the […]